Discover what healthcare professionals (HCPs) think about pharmaceutical products and their manufacturers, as it happens, through CREATION.co’s tracking updates. How are HCPs responding to drug launch news? How are HCPs talking about or engaging with the Top 50 pharma companies on social media? Each week, CREATION.co’s tracking updates bring you the latest insights from the conversation of HCPs across the globe discussing these topics and more.
The Top 50 Pharmaceutical Companies mentioned by HCPs on Twitter
| February Rank | January Rank | Company Name | Total Mentions | Account Mentions | Account Retweets |
|---|---|---|---|---|---|
| 1 | 1 | Pfizer | 9,536 | 637 | 65 |
| 2 | 3 | Johnson & Johnson | 1,186 | 414 | 85 |
| 3 | 2 | AstraZeneca | 913 | 243 | 20 |
| 4 | 5 | GSK | 586 | 182 | 33 |
| 5 | 6 | Abbott | 474 | 447 | 17 |
| 6 | 8 | Roche | 423 | 154 | 36 |
| 7 | 9 | Novartis | 350 | 193 | 21 |
| 8 | 13 | Sanofi | 304 | 119 | 47 |
| 9 | 12 | Gilead Sciences | 227 | 66 | 14 |
| 10 | 7 | Biogen | 221 | 152 | 0 |
| 11 | 11 | Merck & Co | 221 | 135 | 34 |
| 12 | 14 | Bayer | 197 | 88 | 21 |
| 13 | 10 | Lilly | 192 | 95 | 10 |
| 14 | 15 | Novo Nordisk | 188 | 145 | 15 |
| 15 | 17 | Amgen | 105 | 90 | 14 |
| 16 | 16 | Takeda | 101 | 82 | 7 |
| 17 | 18 | AbbVie | 92 | 60 | 8 |
| 18 | 25 | UCB | 90 | 80 | 28 |
| 19 | 4 | Regeneron | 82 | 6 | 1 |
| 20 | 20 | Otsuka | 73 | 1 | 0 |
| 21 | 19 | Boehringer Ingelheim | 65 | 55 | 24 |
| 22 | 22 | BMS | 63 | 46 | 4 |
| 23 | 21 | Fresenius | 53 | 43 | 18 |
| 24 | 26 | Merck KGaA | 53 | 51 | 13 |
| 25 | 30 | Daiichi Sankyo | 53 | 29 | 3 |
| 26 | 27 | Teva | 52 | 40 | 23 |
| 27 | 23 | Chugai | 41 | 1 | 1 |
| 28 | 29 | Ipsen | 36 | 23 | 2 |
| 29 | 31 | Bausch | 28 | 6 | 0 |
| 30 | 38 | CSL | 23 | 23 | 12 |
| 31 | 33 | Allergan | 21 | 1 | 0 |
| 32 | 24 | Eisai | 20 | 15 | 2 |
| 33 | 37 | Menarini | 20 | 16 | 2 |
| 34 | 35 | Astellas | 18 | 13 | 3 |
| 35 | 28 | Servier | 14 | 9 | 0 |
| 36 | 34 | Vertex | 12 | 12 | 0 |
| 37 | 39 | Alexion | 10 | 5 | 0 |
| 38 | 32 | Mylan | 6 | 1 | 0 |
| 39 | 36 | Sun | 6 | 2 | 1 |
| 40 | 40 | Grifols | 1 | 0 | 0 |
| 41 | 41 | Aurobindo | 1 | 0 | 0 |
| 42 | 42 | Mitsubishi Tanabe Pharma | 1 | 1 | 0 |
| 50 | 50 | Jiangsu Hengrui | 0 | 0 | 0 |
| 50 | 50 | Ono | 0 | 0 | 0 |
| 50 | 50 | Endo | 0 | 0 | 0 |
| 50 | 50 | Meiji | 0 | 0 | 0 |
| 50 | 50 | Yunnan Baiyao | 0 | 0 | 0 |
| 50 | 50 | Sino | 0 | 0 | 0 |
| 50 | 50 | Shanghai | 0 | 0 | 0 |
| 50 | 50 | Sumitomo Dainippon | 0 | 0 | 0 |
The latest insights from HCPs mentioning the Top 50 Pharmaceutical Companies
The five pharmaceutical companies that were mentioned the most by healthcare professionals (HCPs) on Twitter during February 2022 were Pfizer, Johnson & Johnson, AstraZeneca, GSK and Abbott.
While COVID-19 vaccination discussions continued to drive the conversation, CREATION.co identified an overall decrease of 7,424 mentions of pharmaceutical companies this month down to 15,207 mentions, with 5,473 fewer COVID-19 mentions. HCPs largely discussed healthcare inequity, comparing the revenue of pharmaceutical companies to the efficacy of their products. In addition, HCPs highlighted the need for vaccine equity in order to end the pandemic.
Pfizer made $37 billion off its Covid vaccine last year, more than the GDP of 120 countries.
Moderna founders made Forbes’ list of richest people.
Yet only 10% of people in low-income countries have been vaccinated.
And Covax—the global dose-sharing initiative—is out of money.
— Craig Spencer MD MPH (@Craig_A_Spencer) February 10, 2022
Instead of hospitals using life saving FDA approved Ivermectin and HCQ they used Remdesivir a drug known for kidney failure, why?
It's all about the money that BIG PHARM could make off using Gilead's taxpayer sponsored Remdesivir.
— Dr. Dawn Michael (@DawnsMission) February 2, 2022
The top shared links by HCPs discussed the availability and efficacy of COVID-19 vaccines:
- A news article by The Washington Post about the availability of the COVID-19 vaccine for children under 5.
- A study produced by the CDC about SARS-CoV-2 Infection and Hospitalisation Among Adults Aged ≥18 Years by vaccination status.
- An article on Nature.com comparing humoral and cellular responses in health care workers receiving two doses of Pfizer-BioNTech vaccine.
COVID-19 made up only 47% of the conversations from HCPs about Top 50 Pharmaceutical companies – the first time since September 2020 that the percentage has been below 50%. This was mostly driven by the discussions about vaccine inequity, and vaccinations of children under 5 years old.
Pfizer expected to submit as early as Tuesday a request to the FDA for emergency-use authorization for the vaccine for children 6 months to 5 years old, which could mean a vaccine for this age group available by the end of February.https://t.co/e9ZxB0imyC
— Dr. Michelle Au (@AuforGA) February 1, 2022
Outside of the COVID-19 conversation, Abbott climbed into the top five in February 2022, with conversations about their contributions within the cardiovascular therapy area.
Left Lateral AP retrograde conduction with LA breakout mapped beautifully with omnipolar GRID on EnSiteX @AbbottCardio @uazmedphx pic.twitter.com/fum6pu3061
— Peter Weiss (@Peteweissmd) February 8, 2022
CREATION.co continues to analyse online HCP conversation on a variety of topics including virtual congress, healthcare changes since the pandemic, product development and therapy area specific insights.
To stay up to date, you can sign up to CREATION.co’s monthly eJournal.
Methodology notes:
- In February 2022, CREATION Pinpoint® identified 15,207 healthcare professional (HCP) authored tweets from 6,363 individual HCPs mentioning a Top 50 Pharmaceutical company (according to revenue).
- Data for this research was analysed from the online Twitter conversations of HCPs in all languages mentioning a Top 50 Pharmaceutical company between 01 February and 28 February 2022.
- Unless otherwise specified, mentions of a company are not limited to its Twitter account(s).
- In some cases, a tweet may mention more than one company account (e.g. @abbottnews and @abbottglobal) – this only counts as one Company Mention and Account Mention.
- Johnson & Johnson was included as a whole, encompassing its pharmaceutical subsidiary, Janssen. In February 227 of these posts mentioned Janssen.
